HeartBeat.bio logo

HeartBeat.bio

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$4.8M


HeartBeat.bio is a biotech company that uses human organoids and AI to develop a drug discovery platform for heart disease.

Total Funding

$4.8M

Headquarters

Vienna, Austria

Founded

N/A

Focus Areas

Biotech
Human Organoid
AI-Supported Drug Discovery
Heart Disease
Cardioid Drug Discovery Platform
Genetic Cardiomyopathies

Investors

aws logo
Tensor Ventures logo
i&i Biotech Fund logo
Invest AG logo